Zydus Lifesciences Financial Results

PartnershipAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Zydus Lifesciences Partnership

Zydus Lifesciences' division Zylidac Bio partnered with Prolific Machines to scale their next-generation biologics manufacturing platform for GMP production.

Regulatory ApprovalAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Zydus Lifesciences Regulatory Approval

Zydus Lifesciences received USFDA approval for its Estradiol-Levonorgestrel Transdermal System ANDA, designated as a CGT. The product is eligible for 180-day exclusivity upon first commercial marketing.

Board Meeting Date

Zydus Lifesciences Board Meeting Date

Zydus Lifesciences intimated a board meeting on 4 Nov 2026 to approve unaudited Q1/H1 FY27 results. Trading window remains closed until 6 Nov 2026.

Other Announcement

Zydus Lifesciences Other Announcement

Zydus Lifesciences Limited has been assigned an ESG rating of 71 by NSRAL for the financial year 2026. This unsolicited rating reflects the company's sustainability performance.

Capacity Expansion

Zydus Lifesciences Capacity Expansion: ₹190 Cr Investment

Zydus' JV with Sunshine Healthcare signed a BOI agreement to establish a pharma plant in Sri Lanka. Investment exceeds USD 20 million (~₹190 Cr), targeting 2028.

Value

₹190.0 Cr

Business Update

Zydus Lifesciences Business Update

Zydus Lifesciences presented post-hoc analysis from its EPICS-III clinical trial for Saroglitazar at ACG 2026. The drug remains under regulatory review for PBC treatment.

Financial ResultsVaibhav Global Ltd VAIBHAVGBL

Vaibhav Global Q2 FY27 Results: Net Profit ₹41.7 Cr, Down 12.4% YoY

Vaibhav Global Ltd reported revenue from operations of ₹938.4 Cr (+7.0% YoY) and net profit of ₹41.7 Cr (-12.4% YoY) for Q2 FY27.

Key figure

Net profit ₹41.7 Cr · -12.4% YoY

Financial ResultsMosChip Technologies Ltd MOSCHIP

MosChip Technologies Q2 FY27 Results: Net Loss of ₹30.4 Cr

MosChip Technologies Ltd reported revenue from operations of ₹119.1 Cr (-18.9% YoY) and a net loss of ₹30.4 Cr for Q2 FY27.

Key figure

Net loss ₹30.4 Cr

Financial ResultsOnMobile Global Ltd ONMOBILE

OnMobile Global Q2 FY27 Results: Net Loss of ₹10.5 Cr

OnMobile Global Ltd reported revenue from operations of ₹127.1 Cr (-0.9% YoY) and a net loss of ₹10.5 Cr for Q2 FY27.

Key figure

Net loss ₹10.5 Cr

Financial ResultsZensar Technologies Ltd ZENSARTECH

Zensar Technologies Q2 FY27 Results: Net Profit ₹190.2 Cr, Up 4.4% YoY

Zensar Technologies Ltd reported revenue from operations of ₹1,585 Cr (+11.5% YoY) and net profit of ₹190.2 Cr (+4.4% YoY) for Q2 FY27.

Key figure

Net profit ₹190.2 Cr · +4.4% YoY

Financial ResultsGMR Airports Ltd GMRAIRPORT

GMR Airports Q2 FY27 Results: Net Profit ₹65.4 Cr, Up 86.3% YoY

GMR Airports Ltd reported revenue from operations of ₹4,095 Cr (+11.6% YoY) and net profit of ₹65.4 Cr (+86.3% YoY) for Q2 FY27.

Key figure

Net profit ₹65.4 Cr · +86.3% YoY

Financial ResultsHexaware Technologies Ltd HEXT

Hexaware Technologies Q2 FY27 Results: Net Profit ₹429.4 Cr, Up 16.1% YoY

Hexaware Technologies Ltd reported revenue from operations of ₹3,933 Cr (+12.9% YoY) and net profit of ₹429.4 Cr (+16.1% YoY) for Q2 FY27.

Key figure

Net profit ₹429.4 Cr · +16.1% YoY